Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

Question 2

How does imatinib compare to other treatments available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of taking imatinib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this treatment affect my surgery schedule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I need while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific lifestyle changes I should consider while on this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans clinical trial (NCT00243191). Contact the study team or your healthcare provider for specific answers.

What this study is about